The evaluation of different factors that cause FEV1 decline in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 135s Year: 2001
Does an acute FEV1 response predict long-term improvements with bronchodilators in patients with COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 486s Year: 2001
Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients Source: Eur Respir J, 57 (3) 2000918; 10.1183/13993003.00918-2020 Year: 2021
Comparison of predictive respiratory function parameters of lung cancer patients having COPD diagnosis with postoperative values and relation with mortality and morbidity Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients Year: 2011
Biomarkers to predict FEV1 decline in smokers and early-onset COPD. Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
Identifying risk groups for any cause hospitalizations in COPD patients Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017
A clinical scoring algorithm to predict all cause mortality in COPD Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007
Is the GOLD guideline for diagnosing obstruction in COPD discriminatory in predicting severe future COPD-related exacerbations and death? Source: Breathe, 17 (4) 210046; 10.1183/20734735.0046-2021 Year: 2021
Validation of bode index as a predictor of mortality in COPD patients Source: Annual Congress 2008 - Prognosis in COPD Year: 2008
The index distance-saturation product like predicting of mortality in patients with COPD Source: Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment Year: 2008
Frequent exacerbations in COPD are associated with accelerated rate of FEV1 decline Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006
FEV1 decline in patients with chronic obstructive pulmonary disease: Which treatment option is better for slowing of decline? Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015
Smoking is predictor of mortality in severe, ex-smokers COPD patients on long term oxygen therapy Source: Eur Respir J 2004; 24: Suppl. 48, 372s Year: 2004
Do cardiac biomarkers predict long-term outcomes from exacerbations of COPD? Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017
GOLD staging and grading for predicting one-year mortality in COPD patients with severe exacerbation Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
The impact on risk-factor analysis of different mortality outcomes in COPD patients Source: Eur Respir J 2008; 32: 629-636 Year: 2008
Frequent exacerbations in ex smokers with COPD are associated with accelerated rate of FEV1 decline Source: Eur Respir J 2005; 26: Suppl. 49, 510s Year: 2005
β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011
Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index. Source: International Congress 2019 – Advances in clinical management of COPD Year: 2019